Who
Stephane Bancel
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Moderna; Director, Generate Biomedicines; Director, Syros Pharmaceuticals; Executive Chairman, BG Medicine; Director, Targanta Therapeutics.
In numbers
- Trades disclosed
- 1,746
- Buys
- 9
- Sells
- 429
- Bought
- $5.2M
- Sold
- $1.3B
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 25 Aug 2008
- Last trade
- 6 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 7 Aug 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —64,928 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —187,541 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —64,928 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | $4.8M252,469 at $19.15 | filing |
| 6 Aug 2026filed 7 Aug 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —187,541 at $0.00 | filing |
| 6 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | $4.8M252,469 at $19.15 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | $9.6M499,246 at $19.15 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $8.3M147,473 at $56.21 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $7.1M124,838 at $56.96 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —370,853 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —128,393 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $2.3M39,891 at $58.12 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $11.0M187,044 at $58.79 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —370,853 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —128,393 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | $9.6M499,246 at $19.15 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $8.3M147,473 at $56.21 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $7.1M124,838 at $56.96 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $2.3M39,891 at $58.12 | filing |
| 5 Aug 2026filed 7 Aug 2026 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $11.0M187,044 at $58.79 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Moderna (NASDAQ:MRNA) Shares Up 1.2% – Here's WhyMRNA · dailypolitical.com · 13 Oct 2026Moderna (MRNA) Was Removed From the Nasdaq-100 and Is Going Back In. What Changed?MRNA · insidermonkey.com · 9 Oct 2026
0 headlines in the last 90 days name Stephane Bancel; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.